(RNR) Renaissancere Holdings - Overview
Sector: Financial Services | Industry: Insurance - Reinsurance | Exchange: NYSE (USA) | Market Cap: 12.601m USD | Total Return: 24.5% in 12m
Avg Turnover: 116M
EPS Trend: 54.2%
Qual. Beats: 0
Rev. Trend: 85.3%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
RenaissanceRe Holdings Ltd. (RNR) is a Bermuda-based global provider of reinsurance and insurance products. The company operates through two primary segments: Property, which focuses on catastrophe excess of loss coverage for natural and man-made disasters, and Casualty and Specialty, which covers diverse risks including professional liability, cyber, and marine. RNR utilizes a distribution model centered on intermediaries and manages third-party capital through various investment funds.
The reinsurance business model functions as a secondary layer of risk management, allowing primary insurers to transfer high-severity loss exposure to maintain solvency. Unlike standard insurance, the property catastrophe sector is characterized by low-frequency but high-severity events that require sophisticated actuarial modeling and significant capital reserves. Investors can further evaluate these risk models and capital structures on ValueRay.
Founded in 1993, the firm has expanded its footprint beyond its initial catastrophe focus to include a broad array of specialty casualty lines. This diversification helps mitigate the volatility inherent in weather-related claims cycles while providing coverage for complex global liabilities such as medical malpractice and political risk.
- Catastrophic weather event frequency influences property reinsurance loss ratios and underwriting income
- Validus Re acquisition integration drives scale and increases casualty segment market share
- Rising interest rate environment enhances net investment income from fixed income portfolios
- Third-party capital management fees provide high-margin revenue through joint ventures and funds
- Global reinsurance pricing cycles dictate premium growth and net underwriting margin expansion
| Net Income: 2.81b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.44 > 1.0 |
| NWC/Revenue: 307.7% < 20% (prev 272.6%; Δ 35.05% < -1%) |
| CFO/TA 0.08 > 3% & CFO 4.22b > Net Income 2.81b |
| Net Debt (-11.5b) to EBITDA (4.64b): -2.48 < 3 |
| Current Ratio: 4.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.6m) vs 12m ago -16.59% < -2% |
| Gross Margin: 55.03% > 18% (prev 0.24%; Δ 5.48k% > 0.5%) |
| Asset Turnover: 21.37% > 50% (prev 23.34%; Δ -1.97% > 0%) |
| Interest Coverage Ratio: 36.91 > 6 (EBITDA TTM 4.64b / Interest Expense TTM 125.6m) |
| A: 0.66 (Total Current Assets 45.3b - Total Current Liabilities 10.0b) / Total Assets 53.7b |
| B: 0.20 (Retained Earnings 10.7b / Total Assets 53.7b) |
| C: 0.09 (EBIT TTM 4.63b / Avg Total Assets 53.7b) |
| D: 0.31 (Book Value of Equity 10.8b / Total Liabilities 35.2b) |
| Altman-Z'' = 5.86 = AAA |
| DSRI: 1.00 (Receivables 12.2b/13.4b, Revenue 11.5b/12.5b) |
| GMI: 0.43 (GM 55.03% / 23.53%) |
| AQI: 0.93 (AQ_t 0.15 / AQ_t-1 0.17) |
| SGI: 0.92 (Revenue 11.5b / 12.5b) |
| TATA: -0.03 (NI 2.81b - CFO 4.22b) / TA 53.7b) |
| Beneish M = -3.68 (Cap -4..+1) = AAA |
As of May 23, 2026, the stock is trading at USD 300.56 with a total of 288,895 shares traded.
Over the past week, the price has changed by +0.45%,
over one month by -4.98%,
over three months by -1.96% and
over the past year by +24.54%.
Renaissancere Holdings has received a consensus analysts rating of 3.42. Therefore, it is recommended to hold RNR.
- StrongBuy: 2
- Buy: 4
- Hold: 4
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 328.1 | 9.2% |
P/E Forward = 9.0662
P/S = 1.0874
P/B = 1.1904
P/EG = 3.6212
Revenue TTM = 11.5b USD
EBIT TTM = 4.63b USD
EBITDA TTM = 4.64b USD
Long Term Debt = 2.33b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -11.5b USD (calculated: Debt 2.33b - CCE 13.8b)
Enterprise Value = 1.09b USD (12.6b + Debt 2.33b - CCE 13.8b)
Interest Coverage Ratio = 36.91 (Ebit TTM 4.63b / Interest Expense TTM 125.6m)
EV/FCF = 0.26x (Enterprise Value 1.09b / FCF TTM 4.18b)
FCF Yield = 385.0% (FCF TTM 4.18b / Enterprise Value 1.09b)
FCF Margin = 36.46% (FCF TTM 4.18b / Revenue TTM 11.5b)
Net Margin = 24.46% (Net Income TTM 2.81b / Revenue TTM 11.5b)
Gross Margin = 55.03% ((Revenue TTM 11.5b - Cost of Revenue TTM 5.16b) / Revenue TTM)
Gross Margin QoQ = 54.75% (prev 67.47%)
Tobins Q-Ratio = 0.02 (Enterprise Value 1.09b / Total Assets 53.7b)
Interest Expense / Debt = 5.39% (Interest Expense 125.6m / Debt 2.33b)
Taxrate = 6.01% (33.0m / 548.8m)
NOPAT = 4.36b (EBIT 4.63b * (1 - 6.01%))
Current Ratio = 3.53 (Total Current Assets 45.3b / Total Current Liabilities 12.8b)
Debt / Equity = 0.20 (Debt 2.33b / totalStockholderEquity, last quarter 11.5b)
Debt / EBITDA = -2.48 (Net Debt -11.5b / EBITDA 4.64b)
Debt / FCF = -2.75 (Net Debt -11.5b / FCF TTM 4.18b)
Total Stockholder Equity = 11.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.23% (Net Income 2.81b / Total Assets 53.7b)
RoE = 24.71% (Net Income TTM 2.81b / Total Stockholder Equity 11.4b)
RoCE = 33.86% (EBIT 4.63b / Capital Employed (Equity 11.4b + L.T.Debt 2.33b))
RoIC = 11.46% (NOPAT 4.36b / Invested Capital 38.0b)
WACC = 6.48% (E(12.6b)/V(14.9b) * Re(6.74%) + D(2.33b)/V(14.9b) * Rd(5.39%) * (1-Tc(0.06)))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -76.41 | Cagr: -7.72%
[DCF] Terminal Value 77.97% ; FCFF base≈3.44b ; Y1≈3.95b ; Y5≈5.81b
[DCF] Fair Price = 2.32k (EV 87.4b - Net Debt -11.5b = Equity 98.9b / Shares 42.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 54.18 | EPS CAGR: 23.92% | SUE: 0.75 | # QB: 0
Revenue Correlation: 85.35 | Revenue CAGR: 20.31% | SUE: -0.73 | # QB: 0
EPS current Quarter (2026-06-30): EPS=10.93 | Chg30d=-1.45% | Revisions=+0% | Analysts=16
EPS next Quarter (2026-09-30): EPS=6.26 | Chg30d=-0.01% | Revisions=-20% | Analysts=4
EPS current Year (2026-12-31): EPS=40.74 | Chg30d=+6.51% | Revisions=+50% | GrowthEPS=+4.2% | GrowthRev=-10.2%
EPS next Year (2027-12-31): EPS=40.94 | Chg30d=-6.53% | Revisions=-14% | GrowthEPS=+28.1% | GrowthRev=+1.4%
[Analyst] Revisions Ratio: +50%